Csenge Advisory Group

SEC CIK: 0001715593
Latest filing: Aug 10, 2026

SEC filings (opens in a new tab)

DFTX holding history

Definium Therapeutics, Inc. in every 13F filed by Csenge Advisory Group, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DFTX overview All 13F holders of DFTX Full Q2 2026 holdings

Shares (Q1 2022): 0; Sold out in Q1 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q2 2021

Holdings of DFTX by Csenge Advisory Group, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2022	0	$0	0.0%	−12,112−100.0%	Sold out	Holders
Q4 2021	12,112	$42.0K	<0.1%	−2,500−17.1%	Reduced	Holders
Q3 2021	14,612	$34.0K	<0.1%	+2,500+20.6%	Added	Holders
Q2 2021	12,112	$42.0K	<0.1%	+12,112	New	Holders